Pharma Deals Review, Vol 2006, No 72 (2006)

Font Size:  Small  Medium  Large

Kos to Market SkyePharma’s Flutiform™

Business Review Editor

Abstract


Kos Life Sciences entered into an exclusive deal with SkyePharma. Under the terms of the agreement, Kos will market and distribute SkyePharma’s Flutiform(TM) in US.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.